Literature DB >> 2474646

Epithelial HLA-DR expression in labial salivary glands in Sjögren's syndrome and non-specific sialadenitis.

P M Speight1, A Cruchley, D M Williams.   

Abstract

The expression of the Class II major histocompatibility antigen HLA-DR was quantified in the epithelial cells of labial salivary glands from patients with Sjögrens Syndrome (SS) and compared with similar expression in glands showing non-specific sialadenitis and normal controls. In all glands more duct cells were positive than acinar cells but only in sialadenitis and SS was strong epithelial staining seen. The proportions of duct and acinar cells expressing HLA-DR were increased between normals and sialadenitis (P less than 0.01) and between sialadenitis and SS (P less than 0.001). However, for all cases increased expression of HLA-DR correlated to the increased proportion of inflammatory cells in the gland (P less than 0.01). The results indicate that although HLA-DR is expressed on the epithelial cells in the glandular lesions of SS, this is not specific as it is also seen in sialadenitis. This supports the view that such expression is secondary to an inflammatory infiltrate and may not be of importance in initiating autoimmune tissue damage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474646     DOI: 10.1111/j.1600-0714.1989.tb00758.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  4 in total

1.  Cytokine and adhesion molecule expression in the minor salivary glands of patients with Sjögren's syndrome and chronic sialoadenitis.

Authors:  A Cauli; G Yanni; C Pitzalis; S Challacombe; G S Panayi
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

2.  An immunohistochemical study of immunological phenomena in minor salivary glands in patients with Sjögren's syndrome.

Authors:  A Caretto; P A Ostuni; F Chieco-Bianchi; B Pedini; A C Spadaccino; M Bagnasco; S Todesco; C Betterle
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

3.  SARS-CoV-2 infection of the oral cavity and saliva.

Authors:  Ni Huang; Paola Pérez; Takafumi Kato; Yu Mikami; Kenichi Okuda; Rodney C Gilmore; Cecilia Domínguez Conde; Billel Gasmi; Sydney Stein; Margaret Beach; Eileen Pelayo; Jose O Maldonado; Bernard A Lafont; Shyh-Ing Jang; Nadia Nasir; Ricardo J Padilla; Valerie A Murrah; Robert Maile; William Lovell; Shannon M Wallet; Natalie M Bowman; Suzanne L Meinig; Matthew C Wolfgang; Saibyasachi N Choudhury; Mark Novotny; Brian D Aevermann; Richard H Scheuermann; Gabrielle Cannon; Carlton W Anderson; Rhianna E Lee; Julie T Marchesan; Mandy Bush; Marcelo Freire; Adam J Kimple; Daniel L Herr; Joseph Rabin; Alison Grazioli; Sanchita Das; Benjamin N French; Thomas Pranzatelli; John A Chiorini; David E Kleiner; Stefania Pittaluga; Stephen M Hewitt; Peter D Burbelo; Daniel Chertow; Karen Frank; Janice Lee; Richard C Boucher; Sarah A Teichmann; Blake M Warner; Kevin M Byrd
Journal:  Nat Med       Date:  2021-03-25       Impact factor: 53.440

4.  Salivary dysbiosis in Sjögren's syndrome and a commensal-mediated immunomodulatory effect of salivary gland epithelial cells.

Authors:  Yu-Chao Tseng; Hsin-Yi Yang; Wei-Ting Lin; Chia-Bin Chang; Hsiu-Chuan Chien; Hon-Pin Wang; Chun-Ming Chen; Jann-Tay Wang; Chin Li; Shu-Fen Wu; Song-Chou Hsieh
Journal:  NPJ Biofilms Microbiomes       Date:  2021-03-11       Impact factor: 7.290

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.